Intelligent Bio Solutions (INBS) announced it has entered into a non-exclusive strategic alliance and collaboration agreement with Vlepis Pty, an Australian medical and wellbeing technology company specializing in advanced sensing and wearable patch technologies, which better positions INBS to enter the consumer health monitoring market. Vlepis’ wearable and software-based technologies complement INBS’ existing portfolio, which includes its Intelligent Fingerprinting Drug Testing Solution and the recently added SMARTOX SmarTest Patch that the Company distributes. “This partnership with Vlepis strengthens our ability to develop innovative testing and monitoring technologies for new sectors,” said Harry Simeonidis, President and CEO at Intelligent Bio Solutions. “By combining our non-invasive technologies and commercial expertise with Vlepis’ pioneering wearable solutions, we can accelerate entry into the consumer health monitoring sector – a market with strong international demand and long-term revenue potential.”
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INBS:
- Intelligent Bio Solutions Initiates Reverse Stock Split
- Intelligent Bio Solutions Inc trading halted, news pending
- Upcoming Stock Splits This Week (December 15 to December 19) – Stay Invested
- Intelligent Bio Solutions Announces Reverse Stock Split
- Intelligent Bio Solutions announces 1-for-10 reverse stock split
